Expert Review of Pharmacoeconomics & Outcomes Research, Volume 15, Issue 4 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 15, Issue 4 (2015)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Volume 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
How do we value a cure?
Don Husereau
Pages: 551-555
Published online: 27 Apr 2015
AbstractforHow do we value a cure? | Full Text | References | PDF (284.8 KB)
  • 2117 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?
Tim A Kanters, Leona Hakkaart, Maureen PMH Rutten-van Mölken & W Ken Redekop
Pages: 557-559
Published online: 14 May 2015
AbstractforAccess to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug? | Full Text | References | PDF (488.4 KB)
  • 1973 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Treatment switching in oncology trials and the acceptability of adjustment methods
Nicholas R Latimer
Pages: 561-564
Published online: 20 Apr 2015
AbstractforTreatment switching in oncology trials and the acceptability of adjustment methods | Full Text | References | PDF (263 KB)
  • 4196 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Memantine for treatment of moderate or severe Alzheimer’s disease patients in urban China: clinical and economic outcomes from a health economic model
Shanlian Hu, Xin Yu, Shengdi Chen, Emilie Clay, Mondher Toumi & Dominique Milea
Pages: 565-578
Published online: 15 Jul 2015
AbstractforMemantine for treatment of moderate or severe Alzheimer’s disease patients in urban China: clinical and economic outcomes from a health economic model | Full Text | References | PDF (835.7 KB)
  • 333 Views
  • 6 CrossRef citations
  • 0Altmetric
Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study
Alfredo Carrato, Pilar García, Rafael López, Teresa Macarulla, Fernando Rivera, Javier Sastre, Joana Gostkorzewicz, Patricia Benedit & Ferran Pérez-Alcántara
Pages: 579-589
Published online: 19 May 2015
AbstractforCost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study | Full Text | References | PDF (653.1 KB)
  • 363 Views
  • 9 CrossRef citations
  • 0Altmetric

Special Report

Patient-centric HTA: different strokes for different folks
Axel C Mühlbacher
Pages: 591-597
Published online: 20 Apr 2015
AbstractforPatient-centric HTA: different strokes for different folks | Full Text | References | PDF (220.6 KB)
  • 286 Views
  • 23 CrossRef citations
  • 0Altmetric

Perspective

End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes?
Alistair McGuire, Michael Drummond, Monique Martin & Nahila Justo
Pages: 599-605
Published online: 15 Jul 2015
AbstractforEnd of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes? | Full Text | References | PDF (279 KB)
  • 242 Views
  • 6 CrossRef citations
  • 0Altmetric

Meeting Report

Initiative to progress research on medicine utilization in Africa: formation of the Medicines Utilization Research in Africa group
Amos Massele, Brian Godman, Matthias Adorka, Joseph Fadare, Andy Gray, Martie Lubbe, Olayinka Ogunleye & Ilse Truter
Pages: 607-610
Published online: 15 Jul 2015
First Page PreviewforInitiative to progress research on medicine utilization in Africa: formation of the Medicines Utilization Research in Africa group | Full Text | References | PDF (166.3 KB)
  • 675 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Review

The cost–effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet
Valentina Lorenzoni, Leopoldo Trieste & Giuseppe Turchetti
Pages: 611-624
Published online: 17 May 2015
AbstractforThe cost–effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet | Full Text | References | PDF (404.6 KB)
  • 386 Views
  • 3 CrossRef citations
  • 0Altmetric
The cost–effectiveness of diagnostic cardiac imaging for stable coronary artery disease
Giuseppe Turchetti, MA Kroes, Valentina Lorenzoni, Leopoldo Trieste, Ann-Marie Chapman, Alison C Sweet, Geoff I Wilson & Danilo Neglia
Pages: 625-633
Published online: 31 May 2015
AbstractforThe cost–effectiveness of diagnostic cardiac imaging for stable coronary artery disease | Full Text | References | PDF (434 KB) | Supplemental
  • 227 Views
  • 7 CrossRef citations
  • 0Altmetric
Hurdles that impede economic evaluations of welfare interventions
Janne Schepers, Lieven Annemans & Steven Simoens
Pages: 635-642
Published online: 11 May 2015
AbstractforHurdles that impede economic evaluations of welfare interventions | Full Text | References | PDF (240.2 KB)
  • 91 Views
  • 3 CrossRef citations
  • 0Altmetric
Development of a conceptual model evaluating the humanistic and economic burden of Crohn’s disease: implications for patient-reported outcomes measurement and economic evaluation
Adam Gater, Helen Kitchen, Louise Heron, Catherine Pollard, Jonas Håkan-Bloch, Lise Højbjerre, Brian Bekker Hansen & Martin Strandberg-Larsen
Pages: 643-656
Published online: 17 May 2015
AbstractforDevelopment of a conceptual model evaluating the humanistic and economic burden of Crohn’s disease: implications for patient-reported outcomes measurement and economic evaluation | Full Text | References | PDF (477.1 KB)
  • 340 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Economic implications of cardiovascular disease management programs: moving beyond one-off experiments
Shoko Maru, Joshua Byrnes, Melinda J Carrington, Simon Stewart & Paul A Scuffham
Pages: 657-666
Published online: 14 May 2015
AbstractforEconomic implications of cardiovascular disease management programs: moving beyond one-off experiments | Full Text | References | PDF (274.9 KB)
  • 165 Views
  • 2 CrossRef citations
  • 0Altmetric
The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland
Paweł P Kawalec & Krzysztof P Malinowski
Pages: 667-673
Published online: 07 Jul 2015
AbstractforThe indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland | Full Text | References | PDF (459.9 KB)
  • 264 Views
  • 18 CrossRef citations
  • 0Altmetric
Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review
Gerardus WJ Frederix, Johan L Severens & Anke M Hövels
Pages: 675-685
Published online: 15 Jul 2015
AbstractforUse of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review | Full Text | References | PDF (328.6 KB)
  • 223 Views
  • 4 CrossRef citations
  • 0Altmetric

Research Report

Article
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand
Panattharin Lerdkiattikorn, Usa Chaikledkaew, Wirote Lausoontornsiri, Somjin Chindavijak, Thirawud Khuhaprema, Narisa Tantai & Yot Teerawattananon
Pages: 687-700
Published online: 18 Oct 2014
AbstractforCost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand | Full Text | References | PDF (519.1 KB)
  • 239 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Societal value of generic medicines beyond cost-saving through reduced prices
Pieter Dylst, Arnold Vulto & Steven Simoens
Pages: 701-711
Published online: 19 Feb 2015
AbstractforSocietal value of generic medicines beyond cost-saving through reduced prices | Full Text | References | PDF (525.7 KB)
  • 321 Views
  • 16 CrossRef citations
  • 0Altmetric
Economic assessment of eltrombopag in the treatment of thrombocytopenia
Federica Romano, Matteo Ruggeri, Silvia Coretti, Edoardo Giovanni Giannini, Dario Sacchini, Brigida Eleonora Annichiarico, Marco Marchetti, Francesco Rodeghiero & Dario Lidonnici
Pages: 713-720
Published online: 15 Jul 2015
AbstractforEconomic assessment of eltrombopag in the treatment of thrombocytopenia | Full Text | References | PDF (848.7 KB) | Supplemental
  • 257 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributes
Ben FM Wijnen, Inge M van der Putten, Siebren Groothuis, Reina JA de Kinderen, Cindy YG Noben, Aggie TG Paulus, Bram LT Ramaekers, Gaston CWM Vogel & Mickael Hiligsmann
Pages: 721-728
Published online: 03 Apr 2015
AbstractforDiscrete-choice experiments versus rating scale exercises to evaluate the importance of attributes | Full Text | References | PDF (329.6 KB)
  • 446 Views
  • 20 CrossRef citations
  • 0Altmetric

Explore articles